Record Details

Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, exosurf and survanta

DSpace at IIT Bombay

View Archive Info
 
 
Field Value
 
Title Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, exosurf and survanta
 
Creator BANERJEE, R
BELLARE, JR
 
Subject dipalmitoyl phosphatidylcholine
antimicrobial activity
pulmonary surfactant
lung surfactant
eugenol
inhibition
films
surfactant
clove oil
wilhelmy balance
pulsating bubble surfactometer
 
Description Dipalmitoyl phosphatidylcholine, the main component of lung surfactant is ineffective as a replacement surfactant due to its poor adsorption. We studied clove oil as a possible additive for improving the surface activity of protein-free phospholipid suspensions. We added low doses of clove oil, to phospholipid suspensions and studied the surface properties by in vitro analysis using a pulsating bubble surfactometer and a Wilhelmy balance. Survanta, ALEC and Exosurf were used as controls for comparison, The test surfactants, which were phospholipid-oil suspensions at 1% concentration, in buffer containing either 2 or 5 mM calcium, were pulsated at 40 cpm in a pulsating bubble surfactometer, The phospholipids studied were dipalmitoyl phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), binary mixtures of PC:PE (2:3) and PC:PG (2:3), The addition of clove oil (CO) to each of the above phospholipids was in the ratio of nine parts of phospholipid to one part of oil. The presence of CO caused a significant improvement in the adsorption and minimum surface tension of all the phospholipid suspensions studied. The mixtures PC with CO, both in the presence of 2 and 5 mM calcium, and PCPE with CO at 2 mM calcium concentration had surface properties significantly better than those of ALEC and Exosurf and equivalent to those of Survanta, The addition of clove oil helps improve the surface properties of phospholipids.
 
Publisher ACADEMIC PRESS LTD
 
Date 2011-07-12T20:31:02Z
2011-12-26T13:02:45Z
2011-12-27T05:49:36Z
2011-07-12T20:31:02Z
2011-12-26T13:02:45Z
2011-12-27T05:49:36Z
2001
 
Type Article
 
Identifier PULMONARY PHARMACOLOGY & THERAPEUTICS, 14(2), 85-91
1094-5539
http://dx.doi.org/10.1006/pupt.2000.0271
http://dspace.library.iitb.ac.in/xmlui/handle/10054/3523
http://hdl.handle.net/10054/3523
 
Language en